Researcher.Life Logo

Journal of Medical Economics : Impact Factor & More

eISSN: 1941-837XpISSN: 1369-6998

Aims and Scope of Journal of Medical Economics

The Journal of Medical Economics is a monthly peer-reviewed academic journal that covers econometric assessments of novel therapeutic and medical device interventions. It is published by Routledge and was established in 1998. The editor-in-chief is K. Lee. Less

Key Metrics

CiteScore
3.7
H-Index
52
Impact Factor
< 5
SJR
Q2Health Policy
SNIP
0.86
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Medical Economics

Journal of Medical Economics Journal Specifications

Overview
Publisher TAYLOR & FRANCIS LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1991
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Medical Economics ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Medical Economics

Statement of Retraction: Foslevodopa/foscarbidopa (LDp/CDp) in advanced Parkinson’s Disease (aPD): demonstration of savings from a societal perspective in the UK
  • 31 Dec 2025
  • Journal of Medical Economics
Comparison of utilization and total medicare fee-for-service expenditures for subcutaneous versus intravenous versions of a select group of therapies
  • 31 Dec 2025
  • Journal of Medical Economics
Assessment of unmet clinical needs and healthcare resource use among statin-treated patients with or at risk of developing atherosclerotic cardiovascular disease
  • 31 Dec 2025
  • Journal of Medical Economics
Treatment patterns and outcomes in patients with lower-risk myelodysplastic syndromes treated with erythropoiesis-stimulating agents in a large US community oncology practice: a retrospective chart review
  • 31 Dec 2025
  • Journal of Medical Economics
Cost-utility analysis of icosapent ethyl in patients with high triglyceride levels and recent acute coronary syndrome in Catalonia
  • 31 Dec 2025
  • Journal of Medical Economics
Correction
  • 31 Dec 2025
  • Journal of Medical Economics
Statement of Retraction: Foslevodopa/foscarbidopa (LDp/CDp) in advanced Parkinson’s Disease (aPD): demonstration of savings from a societal perspective in the UK
  • 31 Dec 2025
  • Journal of Medical Economics
Comparison of utilization and total medicare fee-for-service expenditures for subcutaneous versus intravenous versions of a select group of therapies
  • 31 Dec 2025
  • Journal of Medical Economics
Assessment of unmet clinical needs and healthcare resource use among statin-treated patients with or at risk of developing atherosclerotic cardiovascular disease
  • 31 Dec 2025
  • Journal of Medical Economics
Treatment patterns and outcomes in patients with lower-risk myelodysplastic syndromes treated with erythropoiesis-stimulating agents in a large US community oncology practice: a retrospective chart review
  • 31 Dec 2025
  • Journal of Medical Economics
Cost-utility analysis of icosapent ethyl in patients with high triglyceride levels and recent acute coronary syndrome in Catalonia
  • 31 Dec 2025
  • Journal of Medical Economics
Correction
  • 31 Dec 2025
  • Journal of Medical Economics

FAQs on Journal of Medical Economics